EISSN 2148-5607

TJG IS INDEXED IN SCI-EXPANDED AND PUBMED IMPACT FACTOR: 1.4

Turkish Journal of Gastroenterology

35 414 2024

HIGHLY CITED ARTICLES

HBV and HCV are the risk factors in CCA

Tan et al.

Serum resolvin levels in irritable bowel syndrome

Karatay and Gül Utku

Microbial improvement after intervention

Qian et al.

18F-FDGPET/CT in gallbladder carcinoma

Arslan et al.

Bezoar in endoscopy

Gökbulut et al.

Effect of vitamin D on CD40L gene expression in UC

Sharifi et al.

ERCP for acute cholangitis

Khamaysi and Taha

Inborn metabolic causes of fatty liver disease

Yıldız and Sivri

Gastric and small intestinal TSA

Kiremitci et al.

COVID-19 in Hepatology and Liver transplantation

Kabaçam et al.

Submission to First Decision = 31 Days

Editorial

Chronic liver injury after treatment with carbamazepine and valproic acid

Sebati ÖZDEMİR ¹ , Metin BAŞARANOĞLU ² , Gülşen ÖZBAY ³ , Hakan ŞENTÜRK ⁴ , Perihan AKIN ³

Author Affiliation(s)

1.

İç Hastalıkları anabilim Dalı, İstanbul

2.

İstanbul University Cerrahpasa Medical Faculty, Departments of Hepatology, İstanbul

3.

İstanbul Üniversitesi Cerrahpaşa Tıp Fakültesi İç Hastalıkları, Kardiyoloji, Patoloji Anabilim Dalları, İstanbul

4.

Departments of Internal Medicine, Surgery and Pathology of Cerrahpaşa Medical Faculty of the University of İstanbul

Turk J Gastroenterol 2001; 12: 233-236

Keywords : Carbamazepine, valproic acid, drug-induced liver disease, chronic liver injury..

Read: 1342 Published: 25 July 2019

Volume 12, Issue 3, September 2001

Previous Article